Catalyst News and Research

RSS

Johns Hopkins added as second clinical trial site in Tengion Neo-Urinary Conduit Phase I clinical trial

Tengion, Inc., a leader in regenerative medicine, announced today it has added The Johns Hopkins Hospital in Baltimore, Maryland as a second clinical trial site for its Phase I clinical trial of the Company's lead product candidate, the Tengion Neo-Urinary Conduit™, in bladder cancer patients requiring bladder removal.

10 Sep 2010

ASNM to hold annual conference on nanomedicine

There is enormous excitement and expectation surrounding the multidisciplinary field of nanomedicine the science and technology of diagnosing, treating and preventing disease using nanotechnology. The American Society for Nanomedicine (ASNM) is holding its second annual conference on October 14-16, 2010 in the Washington, D.C. area, where some of the biggest stakeholders in this emerging technology operate and practice.

10 Sep 2010

UCLA plans nanotechnology collaboration with Hamamatsu Photonics

The California NanoSystems Institute at UCLA has announced plans to collaborate with Hamamatsu Photonics Corp., a leading developer and manufacturer of photon detectors and camera systems, to apply nanoscience and nanotechnology to projects having global importance in health, medicine, energy and the environment.

9 Sep 2010

Team of scientists issues HIV vaccine strategy

The Council of the Global HIV Vaccine Enterprise on Tuesday released a new strategy for HIV vaccine research, which marked "the culmination of an 18-month effort that included the input of 400 scientists worldwide," VOA News reports (DeCapua, 9/7).

9 Sep 2010

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

A team of scientists, led by University of California, San Diego School of Medicine researchers, has synthesized hundreds of new compounds with the potential of reducing the production of the A-beta 42 peptide, a primary component of Alzheimer's disease (AD).

9 Sep 2010

DSM Pharma launches InnoSyn route scouting services for pharmaceutical customers

DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, today announced the launch of InnoSyn™ route scouting services. In response to the increasing interest of pharmaceutical customers to outsource the development of robust low-cost manufacturing routes, DSM is offering focused and flexible stand alone route scouting services.

7 Sep 2010

Connecting Kids to Coverage Challenge to enroll five million uninsured children in Medicaid, CHIP

U.S. Department of Health and Human Services Secretary Kathleen Sebelius and U.S. Department of Education Secretary Arne Duncan today highlighted the Connecting Kids to Coverage Challenge to enroll five million children in Medicaid and CHIP within five years. Since Sebelius announced the Challenge last February, the Centers for Medicare & Medicaid Services have built an unprecedented coalition of partners, ranging from state governors to national advocacy organizations, who have stepped up to the challenge to enroll kids and educate families.

4 Sep 2010

AMIA launches non-profit Global Health Informatics Partnership

AMIA, the U.S.-based association for informatics professionals, has launched a non-profit, wholly owned subsidiary organization called the Global Health Informatics Partnership (GHIP) to serve as an international center for collaborative initiatives on health informatics. With generous operational support from AMIA, GHIP, aims to build grassroots networks of health informatics advocates and professionals that will result in strengthened health informatics capacity in low-resource settings, primarily in South America, Africa, and Asia.

3 Sep 2010

Survey finds modest rise in health coverage costs

The Washington Post: "Amid high unemployment and a weak economy, employers have been shifting health care costs to workers, according to a study released Thursday. The premiums that employees pay for employer-sponsored family coverage rose an average of 13.7 percent this year, while the amount that employers contribute fell by 0.9 percent, the survey found.

3 Sep 2010

Greater Cincinnati receives award to improve health care system

U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced today that the Greater Cincinnati community was awarded a $13.8 million Beacon Community cooperative agreement.

3 Sep 2010

SIR issues position statement to determine safety, effectiveness of interventional M.S. treatment

Recognizing that venous interventions may potentially play an important role in treating some patients who suffer from multiple sclerosis an incurable, disabling disease the Society of Interventional Radiology has issued a position statement indicating its support for high quality clinical research to determine the safety and effectiveness of interventional M.S. treatments.

31 Aug 2010

Cell Therapy Foundation analysis calls for funding in medical research

Some of the most promising medical research conducted to treat diseases of the brain, heart, and circulatory system is moving too slowly to help millions of patients, according to the Cell Therapy Foundation, which advocates the use of adult stem cells to dramatically impact and improve the condition of patients who suffer from a variety of conditions.

31 Aug 2010

Scientist finds man-made chemical enzyme to neutralize toxin

For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables. While studying for her PhD in chemistry at the University of Copenhagen Dr. Jeannette Bjerre showed how a novel so called chemzyme was able to decompose glycoside esculin, a toxin found in horse-chestnuts.

27 Aug 2010

Nightingale first-quarter revenue increases to $4.4 million

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the first quarter ended June 30, 2010. All results are reported in Canadian dollars unless otherwise stated.

26 Aug 2010

Administrative Law Judge recommends grant of Certificate of Need for Trinity Medical Center's relocation

Trinity Medical Center achieved a major victory today in its effort to gain state regulatory approval for a new, state-of-the-art hospital facility on Highway 280. Administrative Law Judge (ALJ) James Hampton has issued his recommendation in favor of granting the required Certificate of Need (CON) for Trinity's relocation from its 44-year old campus on Montclair Road to the new hospital facility. The decision follows months of deliberation and a comprehensive review of the facts during what was the longest ALJ hearing on a healthcare matter in Alabama history.

25 Aug 2010

CIMIT, Induct announce strategic alliance to implement Web-based innovation management system

The Center for Integration of Medicine and Innovative Technology and Induct Software, "The Open Innovation Company," today announced a long-term strategic alliance under which they will work together to implement a Web-based innovation management system based upon the successful CIMIT Model.

25 Aug 2010

AdvanSource Biomaterials enters multi-year agreement to supply hydrophilic polymer resins

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that the Company has entered into a multi-year supply agreement with a leading multi-national medical device company. This supply agreement is the result of the Company's successful performance on a development agreement, which was entered into with this customer in June 2009.

25 Aug 2010

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

Alnylam Pharmaceuticals, Inc.,a leading RNAi therapeutics company, announced today that it will make a total of 16 oral presentations at the American Chemical Society (ACS) Fall 2010 240th National Meeting & Exposition being held in Boston, Mass. from August 22-26, 2010.

24 Aug 2010

NCF announces formal disease model for Chronic Fatigue Syndrome

The National CFIDS Foundation Inc., of Needham Mass, has announced its formal disease model for Chronic Fatigue Syndrome (CFS) also known as Chronic Fatigue Immune Dysfunction Syndrome (CFIDS) as well as Myalgic Encephalomyelitis (ME). According to the NCF, a subgroup of patients with CFS fit a unique disease profile based on a model for a radioactive toxin.

21 Aug 2010

MINDBODY receives fund from two venture capital firms

MINDBODY, Inc., the industry leader in cloud-based, business management software for health and wellness organizations worldwide, has received a major investment from two of the country's most respected venture capital firms, Bessemer Venture Partners and Catalyst Investors.

21 Aug 2010

Catalyst News and Research

Johns Hopkins added as second clinical trial site in Tengion Neo-Urinary Conduit Phase I clinical trial

ASNM to hold annual conference on nanomedicine

UCLA plans nanotechnology collaboration with Hamamatsu Photonics

Team of scientists issues HIV vaccine strategy

Researchers synthesize new compounds to reduce A-beta 42 peptide in Alzheimer's disease

DSM Pharma launches InnoSyn route scouting services for pharmaceutical customers

Connecting Kids to Coverage Challenge to enroll five million uninsured children in Medicaid, CHIP

AMIA launches non-profit Global Health Informatics Partnership

Survey finds modest rise in health coverage costs

Greater Cincinnati receives award to improve health care system

SIR issues position statement to determine safety, effectiveness of interventional M.S. treatment

Cell Therapy Foundation analysis calls for funding in medical research

Scientist finds man-made chemical enzyme to neutralize toxin

Nightingale first-quarter revenue increases to $4.4 million

Administrative Law Judge recommends grant of Certificate of Need for Trinity Medical Center's relocation

CIMIT, Induct announce strategic alliance to implement Web-based innovation management system

AdvanSource Biomaterials enters multi-year agreement to supply hydrophilic polymer resins

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

NCF announces formal disease model for Chronic Fatigue Syndrome

MINDBODY receives fund from two venture capital firms

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News